THE INHIBITORY EFFECT OF CELECOXIB ON LUNG CANCER CELL LINE IN VITRO

Jian ZHENG,Dan ZHOU,hong-yi CHEN,Tong-lin LIU,Jian LI
DOI: https://doi.org/10.3969/j.issn.1672-2353.2005.05.014
2005-01-01
Abstract:Objective To observe that celecoxib, a selective inhibitor of cyclooxygenase-2(COX-2), in vitro, inhibited proliferation of cell line of lung cancer. Methods Different doses of celecoxib were added into the lung cancer cell line of A549 to demonstrate its biological function. MTT was performed to reveal the inhibitory effect on cell proliferation. Flow cytometry was used to analyze the effect of celecoxib on cell cycle. VEGF mRNA level in A549 was measured with RT-PCR. Results There was a does-dependent inhibition of cell proliferation by celecoxib. IC50 was 50 μmol/L. Celecoxib induced G_0/G_1 cell cycle arrest, inhibited the G_1 cells to Sphrase transition. Higher level of VEGF mRNA was observed in control than that in test group (P0.05). In addition, the expression level of VEGFmRNA correlated with the concentration of celecoxib. Conclusion Celecoxib inhibited the proliferation of lung cancer cell in vitro, which may account for its inhibitory effect of angiogenesis and iduction of G_0/G_1 cell cycle arrest.
What problem does this paper attempt to address?